Requirement for nuclear factor kappa B signalling in the interleukin-1-induced expression of the CCAAT/enhancer binding protein-δ gene in hepatocytes

Elevated circulating levels of acute phase proteins (APP) are associated with inflammation and inflammatory disorders such as cardiovascular disease. APP are mainly synthesised by hepatocytes and their transcription is induced by pro-inflammatory cytokines such as interleukin-1 (IL-1). The molecular mechanisms underlying the IL-1-induced expression of key transcription factors implicated in the regulation of APP are poorly understood. We have investigated this aspect using the CCAAT/enhancer binding protein-delta (C/EBP delta) as a model gene. IL-1 induced the expression of C/EBP delta mRNA and protein in the human hepatoma Hep3B cell line, a widely employed model system for studies on cytokine signalling in relation to the expression of APP. The IL-1-mediated induction of C/EBP delta expression was attenuated in the presence of pharmacological inhibitors against c-Jun N-terminal kinase (JNK) (curcumin and SP600125), casein kinase 2 (CK2) (apigenin) and nuclear factor-kappa B (NF-kappa B) (NF-kappa B activation inhibitor). RNA interference assays showed significant attenuation of the IL-1-induced expression of C/EBP delta following knockdown of the p50 and p65 subunits of NF-kappa B. IL-1 induced NF-kappa B DNA binding and activation by this transcription factor and this was attenuated by curcumin and apigenin. Taken together, these results suggest a potentially crucial role for NF-kappa B in the IL-1-induced expression of C/EBP delta, and thereby downstream APP genes regulated by this transcription factor. (C) 2009 Elsevier Ltd. All rights reserved.